FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host Disease in Pediatric Patients

The FDA approved Ryoncil, an allogeneic bone marrow–derived mesenchymal stromal cell therapy, for ...

DECEMBER 19, 2024